Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Trip.com Group
TCOM
|
$575M |
| 2 |
DexCom
DXCM
|
$491M |
| 3 |
NVIDIA
NVDA
|
$346M |
| 4 |
ResMed
RMD
|
$334M |
| 5 |
MBLY
Mobileye N.V.
MBLY
|
$282M |
Top Sells
| 1 |
WFM
Whole Foods Market Inc
WFM
|
$281M |
| 2 |
American Express
AXP
|
$255M |
| 3 |
LNKD
LinkedIn Corporation
LNKD
|
$162M |
| 4 |
Stellantis
STLA
|
$113M |
| 5 |
Ryanair
RYAAY
|
$68.8M |
Sector Composition
| 1 | Consumer Discretionary | 35.19% |
| 2 | Communication Services | 18.4% |
| 3 | Healthcare | 14.19% |
| 4 | Financials | 8.31% |
| 5 | Technology | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Ionis Pharmaceuticals
IONS
$9.16B
| $311M | 0.49% |
8,475,347
-188,364
| -2% | -$6.9M |
|
52
Dolby
DLB
$6.91B
| $302M | 0.47% |
5,563,201
-69,937
| -1% | -$3.8M |
|
53
Atlassian
TEAM
$45.3B
| $299M | 0.47% |
9,986,583
+4,471,765
| +81% | +$134M |
|
|
MON
54
DELISTED
Monsanto Co
MON
| $297M | 0.46% |
2,906,963
-66,336
| -2% | -$6.78M |
|
55
DNOW Inc
DNOW
$1.66B
| $289M | 0.45% |
13,495,846
-198,587
| -1% | -$4.26M |
|
|
MBLY
56
DELISTED
Mobileye N.V.
MBLY
| $282M | 0.44% |
+6,621,993
| New | +$282M |
|
57
Mettler-Toledo International
MTD
$26.3B
| $266M | 0.42% |
634,501
-2,214
| -0.3% | -$930K |
|
58
Itaú Unibanco
ITUB
$75.6B
| $240M | 0.38% |
21,909,747
-5,381,109
| -20% | -$58.9M |
|
59
Copa Holdings
CPA
$4.78B
| $237M | 0.37% |
2,694,574
-7,292
| -0.3% | -$641K |
|
|
SRCL
60
DELISTED
Stericycle Inc
SRCL
| $232M | 0.36% |
2,899,617
-40,898
| -1% | -$3.28M |
|
61
Alnylam Pharmaceuticals
ALNY
$58.6B
| $228M | 0.36% |
3,368,325
-21,927
| -0.6% | -$1.49M |
|
62
Myriad Genetics
MYGN
$642M
| $215M | 0.34% |
10,449,822
-871,476
| -8% | -$17.9M |
|
|
QGENF
63
DELISTED
QIAGEN NV
QGENF
| $213M | 0.33% |
7,744,229
-74,199
| -0.9% | -$2.04M |
|
64
Cemex
CX
$13.3B
| $209M | 0.33% |
26,283,894
+220,128
| +0.8% | +$1.75M |
|
65
Howard Hughes
HHH
$4.44B
| $206M | 0.32% |
1,797,791
-13,257
| -0.7% | -$1.52M |
|
66
Kirby Corp
KEX
$5.3B
| $201M | 0.31% |
3,235,008
+14,361
| +0.4% | +$893K |
|
67
Interactive Brokers
IBKR
$28.5B
| $198M | 0.31% |
5,600,548
-38,987
| -0.7% | -$1.38M |
|
68
TAL Education Group
TAL
$6.39B
| $196M | 0.31% |
2,769,083
+1,384,845
| +100% | +$98.1M |
|
|
CBPO
69
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $180M | 0.28% |
1,443,152
-17,600
| -1% | -$2.19M |
|
|
FNGN
70
DELISTED
Financial Engines, Inc.
FNGN
| $174M | 0.27% |
5,852,155
-48,642
| -0.8% | -$1.45M |
|
71
Restaurant Brands International
QSR
$20.5B
| $167M | 0.26% |
3,758,926
-58,231
| -2% | -$2.59M |
|
72
ICICI Bank
IBN
$113B
| $153M | 0.24% |
20,481,387
-236,004
| -1% | -$1.76M |
|
73
Credicorp
BAP
$20.6B
| $146M | 0.23% |
957,236
-61,684
| -6% | -$9.39M |
|
74
Jefferies Financial Group
JEF
$13.2B
| $138M | 0.22% |
7,228,394
-257,633
| -3% | -$4.91M |
|
75
Zillow
Z
$19.8B
| $131M | 0.21% |
3,785,680
-163,662
| -4% | -$5.67M |
|